Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

6 Aug 2014 07:00

RNS Number : 3512O
Avon Rubber PLC
06 August 2014
 

Strictly embargoed until 07:00 Wednesday 6 August 2014

 

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

 

Interim Management Statement for the period 1 April 2014 to 5 August 2014

 

Introduction

Avon is pleased to report that trading has continued to be strong since the end of the first half of our financial year. The Board remains confident that the outturn for the full year, after the impact of an estimated £1.0m currency headwind, will be in line with market expectations.

 

Protection & Defence

The Protection & Defence business has experienced another buoyant period. Further orders worth £25m from the DoD since the half year secure expected sales to this customer for the current financial year and provide a healthy opening order book for next year. We have also seen an increased level of non-DoD orders from customers in the Americas, in particular in the fire services market for our newly approved Deltair SCBA.

 

We are pleased to announce that we are the first supplier to receive approval for our closed circuit escape breathing device (EEBD) under the new NIOSH standard. This approval is an essential requirement under a solicitation by the US Navy which we expect to respond to later this calendar year.

 

Dairy

Market conditions for our Dairy business remain favourable and the investments made in 2013 are now delivering the benefits we expected. In particular our cluster exchange service offering continues to gain momentum in both North America and Europe and we have seen positive third quarter trading in our Chinese business after a slow first half of the year.

 

Foreign exchange translation sensitivity

The Group has a number of US operations and the translation of US$ profits into sterling on consolidation exposes us to foreign exchange translation differences. The average rate of exchange in 2013 was $1.56 / £1. If the current rate of $1.69 / £1 prevails for the remainder of our financial year, the average rate for 2014 is estimated to be $1.67 / £1, and would give rise to a negative currency translation variance compared with 2013 of £1.0m at a profit before tax level.

 

Lawrenceville facility relocation

The relocation of operations from our Lawrenceville facility to our Cadillac facility has progressed to plan. The first shipments of our new Deltair product have been made from Cadillac.

 

Net debt

The Group has seen strong conversion of profits into cash and net debt at 30 June 2014 was £2.6m, which compares to £10.9m at 30 September 2013 and £5.5m at 31 March 2014. During the period the Group successfully negotiated a new and increased $40m revolving credit facility with its bankers which runs to 30 November 2017.

 

Year-end announcement

The Group will announce its results for the year to 30 September 2014 on Wednesday 19 November 2014.

 

 

For further enquiries, please contact:

 

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896831

Andrew Lewis, Group Finance Director

01225 896830

Sarah Matthews-DeMers, Group Financial Controller

01225 896835

Sophie Williams, Group Public Relations Manager

01225 896563

Weber Shandwick Financial

Nick Oborne

020 7067 0700

 

Note to editors: The Group has transformed itself over the past five years into an innovative design and engineering group specialising in two core markets, Protection & Defence and Dairy. With a strong emphasis on research and development we design, test and manufacture specialist products from a number of sites in the US and UK, serving markets around the world. We achieve this through nurturing the talent and aspirations of our employees to realise their highest potential.

Avon Protection is the recognised global market leader in advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection systems technology for the world's military, homeland security, first responder, fire and industrial markets. With an unrivalled pedigree in mask design dating back to the 1920's, Avon Protection's advanced products are the first choice for Personal Protective Equipment (PPE) users worldwide and are placed at the heart of many international defence and tactical PPE deployment strategies. Our expanding global customer base now includes military forces, civil and first line defence troops, emergency service teams and industrial, marine, mineral and oil extraction site personnel. All put their trust in Avon's advanced respiratory solutions to shield them from every possible threat.

Our world-leading Dairy business and its Milkrite brand have a global market presence. With a long history of manufacturing liners and tubing for the dairy industry, Milkrite has become the leading innovator and designer for products and services right at the heart of milking. Our goal is always to improve and maintain animal health. Working with the leading scientists and health specialists in the global dairy industry we continue to invest in technology to further improve the milking process and animal welfare. Our products provide exceptional results for both the animal and the milker, making the milk extraction process run smoothly. As our market share and milking experience continue to grow, so does our global presence.

 

For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSUFWIFLSEEA
Date   Source Headline
27th Sep 20077:01 amRNSAppointments
14th Sep 20077:00 amRNSMoU for Turkish Supply
3rd Sep 200710:30 amRNSTotal Voting Rights
21st Aug 20071:39 pmRNSHolding(s) in Company
3rd Aug 200710:04 amRNSHolding(s) in Company
1st Aug 20072:06 pmRNSTotal Voting Rights
29th Jun 200711:49 amRNSTotal Voting Rights
19th Jun 20077:01 amRNSShare Ownership Trust
18th Jun 20071:42 pmRNSHolding(s) in Company
13th Jun 20074:09 pmRNSShare Ownership Trust
1st Jun 200710:02 amRNSTotal Voting Rights
31st May 20077:02 amRNSInterim Report
17th May 20077:01 amRNSInterim Results
17th May 20077:01 amRNSBoard Appointment
1st May 20079:42 amRNSTotal Voting Rights
30th Apr 20074:36 pmRNSNotice of Results
25th Apr 20079:29 amRNSBlocklisting Interim Review
5th Apr 20074:15 pmRNSHolding(s) in Company
4th Apr 20076:03 pmRNSHolding(s) in Company
2nd Apr 20077:02 amRNSTrading Update
30th Mar 20072:17 pmRNSHolding(s) in Company
16th Mar 200710:10 amRNSHolding(s) in Company
13th Mar 20073:26 pmRNSHolding(s) in Company
9th Mar 200712:59 pmRNSHolding(s) in Company - Amend
8th Mar 20072:45 pmRNSHolding(s) in Company
1st Mar 20079:08 amRNSTotal Voting Rights
6th Feb 200712:41 pmRNSManagement Change
6th Feb 20079:48 amRNSAdditional Listing
1st Feb 20072:41 pmRNSTotal Voting Rights
30th Jan 20071:03 pmRNSHolding(s) in Company
25th Jan 200712:30 pmRNSAnnual General Meeting
25th Jan 20077:01 amRNSAGM Statement
19th Jan 200711:29 amRNSHolding(s) in Company
18th Jan 200711:46 amRNSTotal Voting Rights
12th Jan 200710:00 amRNSAnnual Information Update
5th Jan 200712:51 pmRNSDirector/PDMR Shareholding
3rd Jan 20074:20 pmRNSHolding(s) in Company
22nd Dec 20068:31 amRNSAnnual Report and Accounts
20th Dec 20063:05 pmRNSDirector/PDMR Shareholding
19th Dec 20062:54 pmRNSHolding(s) in Company
14th Dec 200610:55 amRNSDirector/PDMR Shareholding
14th Dec 200610:05 amRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSBoard Changes
12th Dec 20062:27 pmRNSHolding(s) in Company
8th Dec 20064:27 pmRNSTotal Voting Rights
5th Dec 200612:12 pmRNSHolding(s) in Company
1st Dec 20062:24 pmRNSDividend Declaration
30th Nov 20067:03 amRNSFinal Results
7th Nov 20061:01 pmRNSNotice of Results
1st Nov 20062:07 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.